John B. Green

John B. Green has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Dicerna Pharmaceuticals Inc, GTC Biotherapeutics Inc and Verastem, Inc. The record holds 31 filings, for trades running from 10 March 2006 to 20 April 2020.

On the open market, the record shows 5 purchases worth €16k and 8 sales worth €2.6M. The net balance comes to €2.6M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 9 share grants and 9 option exercises. In 2020 alone, the filings show no purchases and 4 sales.

In size, the median ticket on the buying side is €3,298. After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at -27.0%. This is a record of the past, not a forecast.

Most recently, on 22 April 2020, the filings show an option exercise worth €129k in Dicerna Pharmaceuticals Inc. The clock since the last published purchase (30 June 2015) now reads 4,133 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.